In brief, what’s happening at Penn—whether it’s across campus or around the world.
The Penn community joined Black Clergy of Philadelphia and the COVID-19 Prevention Network for a virtual Town Hall discussion called “Faith, (Mis)Trust, and COVID-19.”
FULL STORY AT Leonard Davis Institute →
According to a new study from Penn’s School of Nursing, improving nurse staffing would likely save lives of sepsis patients and save money by reducing the length of hospital stays.
FULL STORY AT Penn Nursing News →
The study, led by principal investigator Bruce Shenker, was awarded funding as part of a National Institutes of Health program to support supplemental COVID-19-related research, receiving a one-year grant extension to Shenker’s grant titled “Bacteria and lymphocyte suppression in periodontitis.”
FULL STORY AT Penn Dental Medicine →
While the pandemic has restricted in-person activities, Penn has found ways to adapt and still safely give back and volunteer.
FULL STORY AT Penn Medicine News →
Partial or full student loan forgiveness is “regressive,” according to a recent working paper by Wharton’s Sylvain Catherine, who argues that any policy that is a universal loan forgiveness policy or a capped forgiveness policy is going to give most of the dollars in forgiveness to upper-income individuals.
FULL STORY AT Knowledge at Wharton →
The associate professor in the Department of Electrical and Systems Engineering, in collaboration with Farshid Ashtiani, a postdoctoral scholar in Aflatouni’s research group, won the top prize for their proposal for “Integrated Photonic-mmWave Deep Networks.”
FULL STORY AT Penn Engineering Today →
The Racial Justice Task Force focused on both short- and long-term recommendations over the course of four months. The recommendations were presented to AD Grace Calhoun and the Division of Recreation and Intercollegiate Athletics (DRIA) executive team and unanimously approved. These recommendations provide direction and intention to DRIA’s efforts to become a more diverse, inclusive, anti-racist organization.
FULL STORY AT Penn Athletics →
A DNA mutation that occurs frequently in the development of many pancreatic tumors appears to make these cancers vulnerable to an existing type of drug known as PARP inhibitors, according to a new study from scientists in the Perelman School of Medicine.
FULL STORY AT Penn Medicine News →
Examining countrywide data, the researchers hoped to gauge how many obstetrician-gynecologists have their waiver to prescribe buprenorphine.
FULL STORY AT Penn Medicine News →
Immune cells called “killer T cells” normally stay in the bloodstream and do not enter organs and other tissues, according to a new study out of the Perelman School of Medicine published in Cell.
FULL STORY AT Penn Medicine News →
